Literature DB >> 31391721

Effect of Atorvastatin on Serum Para-Oxonase-1 and C-Reactive Protein in Wistar Rats.

Aradhana Marathe1, B Ganaraja2, K Ashwin Shenoy1, K Ashok Prabhu1, M Nandini1.   

Abstract

Statins have been widely used in the treatment of hypercholesterolemia and atherosclerotic disease. Atherosclerosis is an ongoing inflammatory response which is involved in mediating all stages of this multifactorial disease. The present study focuses on the long term effect of atorvastatin on the anti-atherogenic and anti-inflammatory properties with reference to para-oxonase and C-reactive protein levels in rats. Thirty six Wistar albino rats obtained from the central animal house were divided into 6 groups with 6 rats in each group. Group I and IV served as the control for male and female rats respectively. Group II and V comprised of male and female rats that received low dose of atorvastatin (10 mg/kg body weight). Group III and VI comprised of male and female rats that received high dose of atorvastatin (40 mg/kg body weight) for period of 45 days. Blood was collected by cardiac puncture. The plasma was analysed for total cholesterol, HDL cholesterol, C-reactive protein (CRP) and Paraoxonase-1, both basal Paraoxonase (BPON) & Salt stimulated Paraoxonase (SPON) by standard procedures. Results of the present study showed a reduction in TC and increase in HDL-C in both groups of rats receiving low and high dose of Atorvastatin. Both male and female rats responded similarly. The levels of CRP decreased in the male rats receiving either low or high dose of atorvastatin. Activity of SPON and BPON was increased only in the group receiving high dose of atorvastatin in both male and female rats.

Entities:  

Keywords:  Atorvastatin; Basal Paraoxonase (BPON); CRP; Cholesterol; Paraoxonase-1; Salt stimulated Paraoxonase (SPON)

Year:  2018        PMID: 31391721      PMCID: PMC6660530          DOI: 10.1007/s12291-018-0742-1

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  28 in total

1.  Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism.

Authors:  C C Hedrick; K Hassan; G P Hough; J H Yoo; S Simzar; C R Quinto; S M Kim; A Dooley; S Langi; S Y Hama; M Navab; J L Witztum; A M Fogelman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-08       Impact factor: 8.311

2.  Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men.

Authors:  M S van der Gaag; A van Tol; L M Scheek; R W James; R Urgert; G Schaafsma; H F Hendriks
Journal:  Atherosclerosis       Date:  1999-12       Impact factor: 5.162

Review 3.  Paraoxonase and atherosclerosis.

Authors:  P N Durrington; B Mackness; M I Mackness
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-04       Impact factor: 8.311

4.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Authors:  P M Ridker; C H Hennekens; J E Buring; N Rifai
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

5.  Clinical efficacy of an automated high-sensitivity C-reactive protein assay.

Authors:  N Rifai; R P Tracy; P M Ridker
Journal:  Clin Chem       Date:  1999-12       Impact factor: 8.327

6.  Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging.

Authors:  R Corti; Z A Fayad; V Fuster; S G Worthley; G Helft; J Chesebro; M Mercuri; J J Badimon
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

7.  Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat.

Authors:  W H Sutherland; R J Walker; S A de Jong; A M van Rij; V Phillips; H L Walker
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-05       Impact factor: 8.311

8.  Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits.

Authors:  M Mackness; A Boullier; N Hennuyer; B Mackness; M Hall; A Tailleux; P Duriez; B Delfly; P Durrington; J C Fruchart; N Duverger; J M Caillaud; G Castro; A Bouiller
Journal:  Biochem Biophys Res Commun       Date:  2000-03-05       Impact factor: 3.575

Review 9.  Cholesterol 2001. Rationale for lipid-lowering in older patients with or without CAD.

Authors:  W S Aronow
Journal:  Geriatrics       Date:  2001-09

Review 10.  Inflammation and atherosclerosis.

Authors:  Peter Libby; Paul M Ridker; Attilio Maseri
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.